![]() |
市場調查報告書
商品編碼
1916601
綠色溶劑和低VOC組合藥物市場,全球預測至2032年:按溶劑類型、應用、最終用戶和地區分類Green Solvents & Low-VOC Formulations Market Forecasts to 2032 - Global Analysis By Solvent Type (Bio-based Solvents, Water-based Solvents, Supercritical Fluids and Ionic Liquids & Deep Eutectic Solvents), Application, End User and By Geography |
||||||
根據 Stratistics MRC 的一項研究,全球綠色溶劑和低 VOC組合藥物市場預計到 2025 年價值 22.9 億美元,到 2032 年達到 40.6 億美元,在預測期內以 8.5% 的複合年成長率成長。
隨著企業將永續性和合規性置於優先地位,綠色溶劑和低VOC組合藥物正逐漸成為首選。這些解決方案透過減少揮發性排放,有助於改善室內空氣質量,並減輕對環境和職業健康的影響。生物基溶劑、水基系統和創新萃取介質等替代方案正逐步取代傳統的溶劑化學方法。日益嚴格的環境法規和消費者對環保產品的需求不斷成長,推動了這些替代方案在油漆塗料、藥品、黏合劑和工業清潔劑等領域的應用。配方技術的持續創新使生產商能夠在不犧牲安全性和效率的前提下,實現與傳統溶劑相當的性能和耐久性。因此,綠色溶劑和低VOC組合藥物正成為現代永續製造實踐的核心。
根據美國環保署 (EPA) 的排放趨勢數據,由於對油漆、塗料和工業溶劑的監管壓力,美國人為 VOC排放已從 1990 年的 2,340 萬噸下降到 2014 年的 1,290 萬噸。
日益成長的健康和職業安全問題
人們日益關注員工健康和用戶安全,這推動了綠色溶劑和低VOC組合藥物的普及。傳統的溶劑型系統通常會排放有害排放,引發呼吸系統疾病、過敏反應和慢性健康問題等風險。為了解決這些問題,越來越多的企業選擇污染物排放量較低、毒性較小的溶劑替代品。更安全的配方有助於改善職場和密閉空間的空氣質量,同時也有助於更安全的操作規範。此外,越來越多的企業採用低VOC產品,以符合安全準則並加強對員工的保護。這種對健康環保化學解決方案日益成長的需求正在推動市場擴張。
生產成本和原料成本高
不斷上漲的製造成本和原料成本正顯著阻礙綠色溶劑和低VOC組合藥物市場的成長。與傳統化學原料相比,生物基原料的採購和加工成本往往較高。先進的生產技術和監管品質標準也推高了營運成本。這些成本壓力推高了產品價格,常常阻礙了對成本敏感的產業採用這些產品。小規模生產商可能難以在保持盈利的同時承擔這些成本。因此,儘管綠色溶劑解決方案具有環境效益,但其高昂的價格限制了其在價格敏感行業的接受度,從而減緩了市場滲透和大規模應用。
綠色化學的技術進步
綠色化學領域的持續創新為綠色溶劑和低VOC組合藥物創造了成長機會。研究成果正在催生新的溶劑替代品和配方方法,這些方法在提高效率的同時還能減少排放。產品性能、耐久性和應用柔軟性的提升,使綠色解決方案在與傳統溶劑的競爭中更具優勢。技術進步也支援客製化,以滿足特定產業的需求,從而增強市場相關性。製造商、學術機構和技術提供者之間的合作進一步推動了產品開發。隨著綠色化學的進步,成本障礙不斷降低,擴大了商業性可行性,並為工業和消費領域的應用開闢了新的途徑。
與傳統溶劑系統和混合溶劑系統的競爭
傳統溶劑系統和部分改質溶劑系統的存在對綠色溶劑和低VOC組合藥物市場構成了激烈的競爭。傳統溶劑產品因其價格實惠、性能穩定且基礎設施成熟而仍然具有吸引力。混合型解決方案雖然能夠適度降低VOC含量並維持較低的轉型成本,但也與完全綠色的替代方案競爭。許多製造商傾向於選擇這些過渡方案,以最大限度地減少營運影響和投資風險。這種趨勢降低了轉型為完全綠色配方的迫切性。來自傳統溶劑系統和混合型系統的競爭,加上既定的行業慣例和對配方變更的抵觸情緒,持續阻礙市場向永續溶劑解決方案轉型的快速進展。
新冠疫情為綠色溶劑和低VOC組合藥物市場帶來了短期挑戰和長期機會。嚴格的封鎖措施和物流中斷最初導致工業生產下降,限制了建築和汽車製造等關鍵終端使用者產業的需求。供不應求和營運延誤進一步限制了市場表現。同時,疫情加劇了人們對人類健康、衛生和環境安全的擔憂。這種轉變增加了醫療、衛生和製藥業對低排放、無毒組合藥物的需求。隨著經濟復甦,製造商更加重視永續和更安全的化學解決方案。因此,新冠疫情造成了暫時的挫折,但從長遠來看,它也將推動綠色溶劑的廣泛應用。
預計在預測期內,水性溶劑細分市場將佔據最大的市場佔有率。
由於其用途廣泛、價格實惠且易於實施,預計水性溶劑將在預測期內佔據最大的市場佔有率。這些配方透過最大限度地減少排放(VOC) 的排放,在無需對製程進行重大更改的情況下,解決了環境和健康問題。它們在塗料、黏合劑、家用清潔劑和工業產品等各種應用中久經考驗的可靠性,使其在眾多行業中得到廣泛認可。水性溶劑易於獲取,並且可以順利整合到現有生產系統中,這使其比新興替代品更具優勢。配方技術的進步提高了黏合強度、表面品質和乾燥特性等性能指標。
預計在預測期內,製藥業將實現最高的複合年成長率。
在對環境責任和人類安全的重視推動下,製藥業預計將在預測期內實現最高成長率。製造商正加速從傳統溶劑轉向環保溶劑,以最大限度地降低毒性、提高職場安全並符合不斷變化的監管標準。永續藥物開發、清潔合成製程和高效溶劑回收利用等方面的努力進一步推動了這一趨勢。全球藥品產量的擴張和藥品需求的成長也促進了該產業的成長。在監管審查日益嚴格和永續性期望不斷提高的背景下,製藥公司正在迅速採用環保型溶劑技術,預計該行業的成長速度將高於其他應用領域。
在預測期內,歐洲地區預計將保持最大的市場佔有率,這得益於嚴格的環境政策和成熟的產業生態系統。以排放和永續性為重點的監管要求正在推動傳統溶劑被環保替代品廣泛取代。塗料、化學和製藥等行業的強大實力帶來了穩定的需求。企業和終端用戶日益增強的環保意識也在加速環保替代品的採用方面發揮關鍵作用。此外,該地區在永續化學解決方案方面擁有強大的研發能力和創新優勢。積極的監管措施、產業的充分準備以及以永續性為中心的策略相結合,將使歐洲能夠繼續保持其在全球綠色溶劑和低VOC組合藥物市場中的最大佔有率。
預計亞太地區在預測期內將實現最高的複合年成長率,這主要得益於強勁的經濟和工業發展。快速的都市化和不斷擴張的產業部門正在推動對環保溶劑解決方案的需求。監管機構日益嚴格的排放限制迫使製造商採用更環保的替代方案。新興經濟體的崛起、化工製造業投資的增加以及跨國公司業務的拓展,都在推動市場擴張。此外,消費者對健康、安全和永續性的日益關注也推動了對低排放產品的需求。隨著這些趨勢的持續發展,預計亞太地區將成為全球成長最快的地區。
According to Stratistics MRC, the Global Green Solvents & Low-VOC Formulations Market is accounted for $2.29 billion in 2025 and is expected to reach $4.06 billion by 2032 growing at a CAGR of 8.5% during the forecast period. Green solvents and low-VOC formulations are emerging as preferred choices as companies prioritize sustainability and regulatory compliance. By lowering volatile emissions, these solutions help enhance indoor air quality and reduce environmental and occupational health impacts. Alternatives such as bio-derived solvents, water-based systems, and innovative extraction media are steadily replacing traditional solvent chemistries. Stricter environmental regulations and growing customer demand for eco-friendly products are driving their use in sectors including paints, coatings, pharmaceuticals, adhesives, and industrial cleaners. Ongoing innovations in formulation technologies allow producers to achieve comparable performance and durability without compromising safety or efficiency. Consequently, green solvents and low-VOC formulations are becoming central to modern, sustainable manufacturing practices.
According to the U.S. EPA emissions trends data, data shows that anthropogenic VOC emissions in the U.S. declined from 23.4 million tons in 1990 to 12.9 million tons in 2014, largely due to regulatory pressure on paints, coatings, and industrial solvents.
Growing health and occupational safety concerns
Rising concerns over employee health and user safety are fueling the shift toward green solvents and low-VOC formulations. Conventional solvent systems are often linked to harmful emissions that pose risks such as breathing problems, allergic reactions, and chronic health effects. To address these issues, companies are increasingly choosing solvent alternatives that release fewer pollutants and are less toxic. Safer formulations help improve air quality in workplaces and enclosed spaces while supporting safer handling practices. Organizations are also motivated to adopt low-VOC products to comply with safety guidelines and enhance workforce protection. This growing emphasis on health-conscious chemical solutions is strengthening market expansion.
High production and raw material costs
Elevated manufacturing and material expenses significantly hinder the growth of the green solvents and low-VOC formulations market. Bio-derived feedstocks typically involve higher sourcing and processing costs compared to traditional chemical raw materials. Advanced production methods and compliance-driven quality standards also contribute to increased operational expenditures. These cost pressures often result in higher product prices, discouraging adoption among cost-conscious industries. Smaller producers may struggle to absorb these expenses while maintaining profitability. Consequently, despite environmental advantages, the premium pricing of green solvent solutions limits their acceptance in price-sensitive sectors, slowing market penetration and large-scale implementation.
Technological advancements in green chemistry
Ongoing innovation in green chemistry presents major opportunities for the growth of green solvents and low-VOC formulations. Research efforts are yielding new solvent alternatives and formulation methods that improve effectiveness while lowering emissions. Enhanced product performance, durability, and application flexibility are making green solutions more competitive with traditional solvents. Technological progress also supports customization for industry-specific requirements, increasing market relevance. Partnerships among manufacturers, academic institutions, and technology providers are further driving product development. As green chemistry advances, it reduces cost barriers and expands commercial viability, opening new avenues for adoption across industrial and consumer-focused applications.
Competition from conventional and hybrid solvent systems
The presence of conventional and partially modified solvent systems presents a strong competitive threat to the green solvents and low-VOC formulations market. Traditional solvent products remain attractive due to their affordability, consistent performance, and mature infrastructure. Hybrid solutions that offer moderate VOC reductions at lower transition costs also compete with fully green alternatives. Many manufacturers prefer these interim options to minimize operational disruption and investment risk. This preference reduces urgency for adopting entirely green formulations. Combined with established industry practices and resistance to reformulation, competition from conventional and hybrid systems continues to restrain rapid market transformation toward sustainable solvent solutions.
The outbreak of COVID-19 created short-term challenges and long-term opportunities for the green solvents and low-VOC formulations market. Strict lockdown measures and logistical interruptions initially reduced industrial output and limited demand from key end-use industries such as construction and automotive manufacturing. Supply shortages and operational delays further constrained market performance. Conversely, the pandemic heightened focus on human health, hygiene, and environmental safety. This shift increased demand for low-emission, non-toxic formulations in healthcare, sanitation, and pharmaceutical products. As economies recovered, manufacturers placed greater emphasis on sustainable and safer chemical solutions. Consequently, while COVID-19 caused temporary setbacks, it ultimately supported stronger adoption of green solvents over time.
The water-based solvents segment is expected to be the largest during the forecast period
The water-based solvents segment is expected to account for the largest market share during the forecast period because of their versatility, affordability, and ease of implementation. By minimizing VOC emissions, these formulations address environmental and health concerns without requiring major process changes. Their proven reliability across applications such as coatings, adhesives, household cleaners, and industrial products supports extensive industry acceptance. Water-based solvents are readily available and integrate smoothly with established production systems, giving them an advantage over emerging alternatives. Advancements in formulation science have improved performance attributes such as adhesion strength, finish quality, and drying behavior.
The pharmaceuticals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pharmaceuticals segment is predicted to witness the highest growth rate, driven by the sector's strong focus on environmental responsibility and human safety. Manufacturers are increasingly replacing conventional solvents with greener alternatives to minimize toxicity, enhance workplace safety, and align with evolving regulatory standards. The push toward sustainable drug development, cleaner synthesis processes, and efficient solvent reuse is further supporting adoption. Expanding pharmaceutical production worldwide and rising demand for medicines is also contributing to growth. As regulatory scrutiny and sustainability expectations continue to rise, pharmaceutical companies are rapidly integrating green solvent technologies, positioning this segment for higher growth than other application areas.
During the forecast period, the Europe region is expected to hold the largest market share, supported by rigorous environmental policies and a mature industrial ecosystem. Regulatory mandates focused on emission reduction and sustainability has driven widespread replacement of conventional solvents with eco-friendly alternatives. Strong presence of industries such as coatings, chemicals, and pharmaceuticals contributes to consistent demand. Environmental consciousness among businesses and end users also plays a crucial role in accelerating adoption. Furthermore, the region benefits from robust research capabilities and innovation in sustainable chemistry solutions. Together, proactive regulations, industrial readiness, and sustainability-driven strategies enable Europe to maintain the largest share in the global green solvents and low-VOC formulations market.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, supported by strong economic and industrial development. Rapid urbanization and expanding industrial sectors are increasing the need for environmentally responsible solvent solutions. Regulatory bodies are introducing stricter guidelines on emissions, prompting manufacturers to adopt greener alternatives. The presence of emerging economies, rising investments in chemical manufacturing and growing participation of multinational companies accelerate market expansion. Furthermore, increasing consumer focus on health, safety, and sustainability is boosting demand for low-emission products. As these trends continue, Asia-Pacific is set to achieve the highest growth rate globally.
Key players in the market
Some of the key players in Green Solvents & Low-VOC Formulations Market include Dow Inc., BASF SE, Evonik Industries AG, Ashland Global Holdings Inc., Clariant AG, Corbion N.V., Archer Daniels Midland Company, Cargill, Incorporated, Solvay, Stepan Company, Vertec BioSolvents, LyondellBasell Industries N.V., Huntsman Corporation, Eastman Chemical Company and AkzoNobel.
In October 2025, Dow and MEGlobal have finalized an agreement for Dow to supply an additional equivalent to 100 KTA of ethylene from its Gulf Coast operations. The ethylene will serve as a key feedstock for MEGlobal's ethylene glycol (EG) manufacturing facility co-located at Dow's and MEGlobal's Oyster Creek site.
In October 2025, BASF and IFF Launch Strategic Partnership for Next-Gen Enzyme and Polymer Innovations. The aim of the collaboration between BASF and IFF is to accelerate the development of IFF's Designed Enzymatic Biomaterials technology platform and to develop next-generation enzyme technologies for applications in detergents, industrial cleaning and personal care products.
In March 2025, Evonik has entered into an exclusive agreement with the Cleveland-based Sea-Land Chemical Company for the distribution of its cleaning solutions in the U.S. The agreement builds on a long-standing relationship with the distributor and expands the reach of Evonik's cleaning solutions to the entire U.S. region.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.